Subgroup | Included studies | Pooled prevalence(%) and 95% CI | Total number of enterococci | I2 Heterogeneity | Heterogeneity test, P value | Publication bias testing | |
---|---|---|---|---|---|---|---|
Egger’s test | Begg’s test | ||||||
Based on AST | |||||||
VRE among total enterococci by disk diffusion method | 13 | 24.02 (11.36 to 39.6) | 866 | 96.05% | P < 0.0001 | P = 0.0480* | P = 0.0231* |
VRE among total enterococci by MIC-based methods | 12 | 28.25 (15.83 to 42.64) | 849 | 94.85% | P < 0.0001 | P = 0.3244 | P = 0.6286 |
VRE among total enterococci by Broth microdilution | 5 | 26.76 (5.9 to 55.6) | 273 | 95.81% | P < 0.0001 | N/PA | N/P |
VRE among total enterococci by E test | 5 | 38.24 (24.7 to 52.78) | 395 | 87.60% | P < 0.0001 | N/P | N/P |
VRE among total enterococci by VITEK 2 Automated System | 3 | 13 (5.17 to 23.64) | 213 | 66.53% | P = 0.0504 | N/P | N/P |
Government | |||||||
Mansoura | 6 | 12.45 (3.97 to 24.74) | 410 | 90.61% | P < 0.0001 | N/P | N/P |
Cairo | 6 | 19.54 (8 to 34.5) | 425 | 91.66% | P < 0.0001 | N/P | N/P |
Minia | 3 | 55.5 (0.186 to 99.5) | 123 | 98.74% | P < 0.0001 | N/P | N/P |
Tanta | 2 | 12 (3.2 to 25.5) | 143 | 69.93% | P = 0.0682 | N/P | N/P |
Menoufia | 2 | 62.5 (51 to 73.3) | 70 | 0.00% | P = 0.7605 | N/P | N/P |
Zagazig | 2 | 21.7 (3.4 to 49.8) | 289 | 96.26% | P < 0.0001 | N/P | N/P |
Sohag | 2 | 52.4 (26.7 to 77.5) | 125 | 89.08% | P = 0.0025 | N/P | N/P |